Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism. / Linnet, Kristian; Wiborg, O.
I: Clinical Pharmacology and Therapeutics, Bind 60, 1996, s. 41-47.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
Linnet, K & Wiborg, O 1996, 'Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism', Clinical Pharmacology and Therapeutics, bind 60, s. 41-47.
APA
Linnet, K., & Wiborg, O. (1996). Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism. Clinical Pharmacology and Therapeutics, 60, 41-47.
Vancouver
Linnet K, Wiborg O. Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism. Clinical Pharmacology and Therapeutics. 1996;60:41-47.
Author
Bibtex
@article{7b840cc776954a8d8552e4b1395ed724,
title = "Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism",
author = "Kristian Linnet and O Wiborg",
year = "1996",
language = "English",
volume = "60",
pages = "41--47",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "JohnWiley & Sons, Inc.",
}
RIS
TY - JOUR
T1 - Steady-state serum concentrations of the neuroleptic perphenazine in relation to CYP2D6 genetic polymorphism
AU - Linnet, Kristian
AU - Wiborg, O
PY - 1996
Y1 - 1996
M3 - Journal article
VL - 60
SP - 41
EP - 47
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
SN - 0009-9236
ER -
ID: 43972513